Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY: DVA )

94.19 +1.77 (+1.92%)
Streaming Delayed Price Updated: 12:56 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DaVita HealthCare Partner

< Previous 1 2 3 4 Next >
Looking Into DaVita's Return On Invested Capital
 
Via Benzinga
Why Buffett Loves These 3 Stocks
An interviewer once asked Warren Buffett about the worst trade he’d ever made… and he didn’t hesitate to answer… Buying Berkshire Hathaway. 
Via Benzinga
DaVita Stock Sees Rising Relative Strength
On Wednesday, DaVita stock cleared a key technical benchmark, seeing its Relative Strength (RS) Rating jump to 91, up from 78 the day before. 
Via Investor's Business Daily
The Latest Analyst Ratings for DaVita
 
Via Benzinga
These 2 Stocks Are Popping -- and It Could Be Just the Beginning
Even in a down market, these companies stood out. 
Via The Motley Fool
VIX Rallies Amid Quiet Day On Wall Street
Wall Street is relatively quiet today, as investors continue to await this week's inflation data. 
Via Talk Markets
Why Shares of DaVita Were Up Tuesday
The dialysis company's raised guidance encouraged investors. 
Via The Motley Fool
DaVita (DVA) Q1 2023 Earnings Call Transcript
DVA earnings call for the period ending March 31, 2023. 
Via The Motley Fool
DaVita (DVA) Q4 2022 Earnings Call Transcript
DVA earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Here's How Much You Would Have Made Owning DaVita Stock In The Last 20 Years
 
Via Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. 
Via Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Here's How Much $1000 Invested In DaVita 20 Years Ago Would Be Worth Today
 
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
 
Via Benzinga
Warren Buffett Owns More Than a 23% Stake in These 3 Stocks
Many institutional investors don't like to purchase more than a 10% stake in a company. 
Via The Motley Fool
3 Medical Device Stocks to Buy for Cutting-Edge Innovation and Growth
Medical device stocks are set to rise with an aging population and continued improvements in technology. Here are 3 stocks to watch. 
Via InvestorPlace
You Won't Believe How Much More Warren Buffett Has Made Than the Market Since 1965
The trick is waiting long enough to let the magic of compounding do its work. 
Via The Motley Fool
The 7 Best Beaten-Down Warren Buffett Stocks to Buy
Investors will want to take a close look at these beaten-down Warren Buffett stocks to buy for long-term appreciation. 
Via InvestorPlace
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the  SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth, 
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,500 Today
 
Via Benzinga
Sell These 3 Stocks and Kick These Overpaid CEOs Out of Your Portfolio
Now is the time to cut your losses on some of your 2022 losers. Here are three stocks to sell whose CEOs didn’t earn their keep. 
Via InvestorPlace
Siemens Healthineers, GE Healthcare Studying Potential Deals With Medtronic's Spun Off Units
 
Via Benzinga
Warren Buffett Now Owns 20% or More of These 5 Companies
Which are these big Buffett bets are the best picks for investors? 
Via The Motley Fool
$1000 Invested In DaVita 20 Years Ago Would Be Worth This Much Today
DaVita (NYSE:DVA) has outperformed the market over the past 20 years by 3.82% on an annualized basis producing an average annual return of 11.29%. Currently, DaVita has a market capitalization of $6.29... 
Via Benzinga
DaVita Earnings Perspective: Return On Capital Employed
Pulled from Benzinga Pro data, DaVita (NYSE:DVA) showed a loss in earnings since Q2, totaling $164.69 million. Sales, on the other hand, increased by 0.75% to $2.95 billion during Q3. 
Via Benzinga
Around $134 Million Bet On This Stock Up 46% Year-To-Date? 3 Stocks Insiders Are Buying
Although US stocks closed lower on Tuesday, there were a few notable insider trades. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  During Monday's session, 96 stocks hit new 52-week lows. 
Via Benzinga
Analyst Ratings for DaVita
Over the past 3 months, 5 analysts have published their opinion on DaVita (NYSE:DVA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
Upgrades 
Via Benzinga
Chevron To Rally Around 21%? Here Are 5 Other Price Target Changes For Monday
Raymond James raised Chevron Corporation (NYSE: CVX) price target from $188 to $215. Raymond James analyst Justin Jenkins maintained the stock with an Outperform rating. Chevron shares fell 1.1% to... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.